Private Equity
Private Equity
All Portfolio items
See full Private Equity portfolio
DETAX is a leading global supplier of biocompatible silicones and light-curing 3D resins for medical applications in the dental and audio sector. End users of the products include dental practices, dental laboratories as well as audiologists and audio laboratories. The group operates in a non-cyclical, highly regulated market environment. Complying with such regulation, DETAX holds all relevant MDR certificates.
DETAX aims to grow its leading market position through development of new high-quality dental & audio materials, further internationalization, continued expansion of strategic partnerships and acquisitions.
More Detax news
Jecture
Jecture focuses on designing and contract manufacturing tailor-made, complex cannulas and cannula systems for pharmaceutical...
Chr. Diener / Koscher & Würtz
With the acquisition of Chr. Diener in 2022 and Koscher & Würtz (K&W) in 2023,...
Tandarts Today
Tandarts Today is a fast-growing chain of dental practices and dental laboratories with a distinctive...